Form 8-K - Current report:
SEC Accession No. 0000927653-22-000015
Filing Date
2022-02-02
Accepted
2022-02-02 16:08:30
Documents
16
Period of Report
2022-02-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mck-20220202.htm   iXBRL 8-K 45238
2 EX-99.1 EX-99.1 EARNINGS RELEASE 12.31.2021 3Q22 mck_exhibit991x12312021.htm EX-99.1 791499
7 LOGO2 mck-20220202_g1.jpg GRAPHIC 11380
8 LOGO mckessonlogoa03a.jpg GRAPHIC 11380
  Complete submission text file 0000927653-22-000015.txt   1132016

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mck-20220202.xsd EX-101.SCH 3365
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mck-20220202_def.xml EX-101.DEF 16807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mck-20220202_lab.xml EX-101.LAB 34230
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mck-20220202_pre.xml EX-101.PRE 17599
10 EXTRACTED XBRL INSTANCE DOCUMENT mck-20220202_htm.xml XML 17784
Mailing Address 6555 STATE HIGHWAY 161 IRVING TX 75039
Business Address 6555 STATE HIGHWAY 161 IRVING TX 75039 972-446-4800
MCKESSON CORP (Filer) CIK: 0000927653 (see all company filings)

EIN.: 943207296 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-13252 | Film No.: 22583681
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries